$0.4290
-0.0105-2.39%
마지막 업데이트: Oct 16, 7:49 PM
$0.4288
-0.0107-2.43%
Benzinga
Benzinga
Benzinga
토요일, 10월 17
Benzinga
© 2026 Benzinga | All Rights Reserved
Humacyte (HUMA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.10 | $-0.11 | $-0.13 | $-0.16 |
| Actual | $-0.16 | $-0.09 | $-0.13 | $-0.11 |
| Surprise | -60.0% | +18.2% | 0.00% | +31.3% |
| Revenue | ||||
| Estimate | $1.2M | $1.4M | $1.4M | $921698 |
| Actual | $406000 | $495000 | $467000 | $753000 |
| Surprise | -65.3% | -65.1% | -67.6% | -18.3% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.08 | $-0.08 | $-0.08 | $-0.08 |
| Revenue | ||||
| Consensus | $788000 | $1.9M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.16 | $-0.10 | -60.0 % |
| Q1 | May 13, 2026 | $-0.09 | $-0.11 | 18.2 % |
| Q4 | Mar 27, 2026 | $-0.13 | $-0.13 | 0.00 % |
| Q3 | Nov 12, 2025 | $-0.11 | $-0.16 | 31.3 % |
| 회계 분기 | 보고된 날짜 | 실제 수익 | 예상 수익 | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $406.00K | $1.17M | -65.3 % |
| Q1 | May 13, 2026 | $495.00K | $1.42M | -65.1 % |
| Q4 | Mar 27, 2026 | $467.00K | $1.44M | -67.6 % |
| Q3 | Nov 12, 2025 | $753.00K | $921.70K | -18.3 % |